A Virginia bank's office count will fall from 33 to 28 by year-end

FIRST NATIONAL CORP /VA/ (FXNC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 First National Corporation Reports SECOND Quarter 2026 FINANCIAL PERFORMANCE STRASBURG, Va., July 29, 2026 --- First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported consolidated ne

First National Corporation (NASDAQ: FXNC) reported Q2 2026 net income of $5.7 million and EPS of $0.64 basic and $0.63 diluted for the quarter ended June 30, 2026. Results included net interest margin of 4.15% FTE, net interest income of $20.1 million, and a $426k credit loss provision. The company said regulatory approvals were received for a pending sale of North Carolina branches expected to close in early Q4 2026.

First National Corp. (NASDAQ:FXNC) declared a quarterly dividend of $0.17 per share, payable June 12 to shareholders of record May 29. The company said the ex-dividend date is May 29. The dividend implies a 2.4% yield and is covered by earnings, with analysts expecting $2.54 EPS next year.

LG Display (LPL) reported Q3 2026 net income of KRW 755.6 billion, with operating profit margin at 4% and EBITDA at 19%. Area shipment grew 4% Q-o-Q to 3.7 million square meters, and ASP rose 16% to $1,250. OLED products accounted for 67% of revenue. The company expects Q4 shipment growth of around 10% but modest ASP increases due to market uncertainties. LG Display is focusing on OLED technology, including its next-gen FLiPP technology, to maintain competitiveness and profitability.

Dr. Reddy’s Laboratories reported fiscal Q2 2027 revenues of ₹8,671 crores, down 1.5% YoY but up 7% sequentially. EBITDA margin was 20.6%, with profit after tax at ₹925 crores. North America sales declined 23% YoY due to lenalidomide, but other regions showed growth. The company announced strategic partnerships and product developments, including a dengue vaccine and biosimilars. Shares rose 0.45% to $13.29 post-results.

GrafTech International (EAF) reported Q3 2026 revenue of $140M, beating estimates but with a wider net loss of $47M. Shares surged 20% on cost cuts and pricing momentum. Management expects improved pricing in 2027, supported by strategic cost reductions and industry trends.